Runs data centers for AI computing, leased largely to CoreWeave, and mines bitcoin.
$13.48close as of 2026-10-16
-31.5% over 1Y · 48.2 points behind the S&P 500
CORZS&P 500 (SPY), rebased to CORZ's first close
“How quickly can Core Scientific turn its AMD agreements into billable capacity while funding the remaining buildout?”
Editorial note · updated 2026-10-07
The TenQ Radar
Core Scientific in 36 checks
Core Scientific on the TenQ Radar: value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.
The business itself is the question here: 4 of 36 checks passed.
The Core Scientific story
What drives Core Scientific, what its price assumes and what could change the story, written from its own filings.
Colocation takes over. In the quarter to June 2026, colocation generated $136.7 million of Core Scientific’s $164.2 million in total revenue.
Contracts precede billing. Total leased customer power capacity reached approximately 1.1 GW, while capacity being billed reached 437 MW as of mid-July 2026.
Construction consumes cash. Capital expenditures reached $797.5 million in the quarter to June 2026, while free cash flow over the last twelve months was -$958 million.
Q2 '26 · quarter to 30 June 2026 · reported 28 July 2026 · Earnings release ↗
Revenue$164M+109%vs 2025+42%vs Q1
Earnings-$1.2B-$219Mvs 2025-$808Mvs Q1
What the release says
Highlights
Core Scientific announced a partnership with AMD that could support up to 2.5 GW of leasable capacity, anchored by 15-year agreements for approximately 530 MW across five sites and more than $14 billion of potential base contracted revenue.
Total leased customer power capacity increased to approximately 1.1 GW, representing more than $24 billion of potential contracted revenue.
As of mid-July, the company was billing for 437 MW of capacity, equating to approximately $635 million in average annualized colocation GAAP revenue.
Net loss for the quarter was primarily driven by a change in fair value of warrants, reflecting appreciation in the company’s stock price during the period.
Key risks
New The company may be unable to attract new high-density colocation customers, which could constrain growth and leave revenue dependent on a single counterparty, exposing the company to heightened risk if that customer reduces, delays, or terminates its commitments.
The company's high-density colocation business is currently highly dependent on a single customer, CoreWeave, which accounts for 100% of Colocation segment revenue, and any disruption in this relationship could materially affect business, financial condition, and results of operations.
Delays or failures in converting existing facilities or constructing new ones to support high-density colocation customers, due to supply chain issues, construction delays, financing challenges, or severe weather, could harm the company's ability to grow and impact financial results.
The company’s success depends on continued demand for high-density colocation applications such as cloud computing, machine learning, and artificial intelligence, and a reduction in demand or rapid technological disruption could reduce revenue and profitability.
The business is capital intensive, and failure to obtain necessary capital when needed could force the company to delay, limit, or terminate expansion efforts or other operations, adversely affecting business, financial condition, and results of operations.
AI summary of the company's filings, every number checked against them · 8 October 2026 · Sources: earnings release, 10-K, 10-Q
Earnings alerts
An email when Core Scientific reports, with its results and highlights. Free with a watchlist account.
I
Value
●●●●●●0/6
Expensive against its own history and its sector (judged on sales, as it is not yet profitable): the price asks a lot of the business.
-no history
9.8xno history
-22.1%cash earned per $ of price
-whole-business multiple
What does “Value” actually mean?
Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.
no positive three-year earnings growth behind the price
II
Growth
●●●●●●1/6
Growth is weak or inconsistent. The trend, not the story, is the problem.
+26.4%vs the year before
-20.7%compound annual
-net income growth
-compound annual
Revenue history
Is CORZ's revenue growing?
◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Revenue ($)
Q1 2021
54.2M
Q2 2021
75.3M
Q3 2021
113.1M
Q4 2021
301.8M
Q1 2022
192.5M
Q2 2022
164.0M
Q3 2022
162.6M
Q4 2022
121.3M
Q1 2023
120.7M
Q2 2023
126.9M
Q3 2023
112.9M
Q4 2023
141.9M
Q1 2024
179.3M
Q2 2024
141.1M
Q3 2024
95.4M
Q4 2024
94.9M
Q1 2025
79.5M
Q2 2025
78.6M
Q3 2025
81.1M
Q4 2025
79.8M
Q1 2026
115.2M
Q2 2026
164.2M
2020
60.3M
2021
544.5M
2022
640.3M
2023
502.4M
2024
510.7M
2025
319.0M
→Revenue reached $319M in 2025, compounding -21% a year since 2022 though the path has been bumpy. The trailing twelve months are already running at $440M, ahead of the last full year.
What this measures
The money customers paid, before any costs are taken out. Each bar is one quarter or, on the annual view, a full financial year; the last annual bar may be the trailing twelve months, which the footnote marks.
What good looks like. Growth that repeats, rather than one strong year carrying the chart, and a trailing twelve months keeping pace with the last full year.
If it rises or falls. Revenue is the hardest line to flatter, so a rise is the most trustworthy kind of growth. A fall puts pressure on every margin below it, because costs rarely come down as quickly as sales do.
Profit history
Is CORZ's net profit growing?
◌ dashed quarter = Q4 derived from the annual filing minus Q1, Q2 and Q3 (the SEC never receives a Q4 report)
Period
Net income ($)
Q1 2021
6.8M
Q2 2021
-3.4M
Q3 2021
-16.6M
Q4 2021
60.5M
Q1 2022
-466.2M
Q2 2022
-810.5M
Q3 2022
-434.8M
Q4 2022
-434.8M
Q1 2023
-388,000
Q2 2023
-9.3M
Q3 2023
-41.1M
Q4 2023
-195.7M
Q1 2024
210.7M
Q2 2024
-902.2M
Q3 2024
-455.3M
Q4 2024
-291.1M
Q1 2025
576.3M
Q2 2025
-936.8M
Q3 2025
-144.0M
Q4 2025
216.0M
Q1 2026
-347.2M
Q2 2026
-1.16B
2020
-12.2M
2021
47.3M
2022
-2.15B
2023
-246.5M
2024
-1.44B
2025
-288.6M
→The company lost $289M in 2025, less than the $1.4B it lost the year before. The losses are narrowing, but it is still burning shareholder money.
What this measures
What is left after every cost, including tax and interest. The bottom line of the income statement.
What good looks like. Profit growing at least as fast as revenue, which means the business is keeping more of each sale as it gets bigger.
If it rises or falls. Profit can move for reasons revenue cannot explain - a one-off charge, a tax change, a write-down - so a single sharp year is worth checking against the margin chart before reading it as a trend.
Growth rate
How fast are CORZ's revenue and earnings growing?
Shown separately because they would flatten the axis: 2022 earnings -4637% - rebounds off a collapsed prior year.
Year
Revenue growth
Earnings growth
2,021
8.0266
-
2,022
0.176
-
2,023
-0.2154
-
2,024
0.0165
-
2,025
-0.3753
-
2026
0.2637
-
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly views, growth is the trailing twelve months against the twelve before, or a quarter against the same quarter a year earlier
→Revenue grew 26% over the twelve months to 2026-06-30, against an average of +153% a year over 2021-2025.
What this measures
How much revenue and earnings changed against the year before - the trailing twelve months against the twelve before them at each quarter, or one point per fiscal year. It is the speed of the business, not its size.
What good looks like. The earnings line above the revenue line: profits growing faster than sales means each new dollar of sales arrives more profitably than the last.
If it rises or falls. A high growth rate off a small base is easy and gets harder every year, so slowing growth in a large business is normal rather than a warning. Earnings falling while revenue grows is the combination worth understanding: costs are rising faster than sales.
Per-share growth
Are CORZ's revenue and free cash flow per share growing?
Year
Revenue per share ($)
Free cash flow per share ($)
2,020
0.3827
-0.1508
2,021
2.3338
-0.2432
2,022
1.8797
-0.5249
2,023
1.3226
0.1289
2,024
1.9961
-0.2035
2,025
1.003
-1.4171
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Revenue per share reached $1.00 in 2025, compounding -19% a year against -21% for CORZ as a whole. Buybacks added roughly 1.8 points to your per-share result. The trailing twelve months are running at $1.38 a share. Free cash flow per share stands at $-1.42.
What this measures
Revenue and free cash flow, each divided by the number of shares in issue and adjusted for splits so old and new years compare honestly. Both lines rising means each share owns more of the business's sales and cash.
What good looks like. Both lines rising, and revenue per share growing at least as fast as the company's total revenue, which the answer compares. Faster means buybacks are working for you; slower means new shares are absorbing part of the growth.
If it rises or falls. This is the line that actually reaches you. A company can grow revenue every year and still shrink your slice by issuing shares faster than it grows.
What does “Growth” actually mean?
Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).
Profitability is thin or negative. The growth isn't turning into money yet.
-kept after direct costs
-127.4%kept after running costs
-profit on shareholders' money
-22.3%against a 10% cost of capital
-operating cash ÷ net income
Margins
What profit margin does CORZ keep on each sale?
Year
Gross
Operating
Net
2,020
-
-0.1049
-0.2024
2,021
-
0.2415
0.0869
2,022
-
-3.2946
-3.352
2,023
-
0.0178
-0.4906
2,024
-
-0.2782
-2.8157
2,025
-
-0.7698
-0.9047
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→Operating margin widened 252 points to -77% since 2022. The bottom line is still negative: costs below the operating line eat what is left. CORZ doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.
What this measures
What survives at three points on the way down the income statement: after the direct cost of the product, after the cost of running the company, and after everything.
What good looks like. Margins that hold or widen as the business grows. The level itself varies enormously by industry, so the shape over time tells you more than the number.
If it rises or falls. A widening margin means pricing power or costs under control. A compressing one means the opposite, and it compounds: on large revenue, two points of margin is a great deal of profit.
Earnings quality
Does CORZ's operating cash flow keep up with its profit?
Year
Cash from operations
Net income
2,020
-23.8M
-12.2M
2,021
-56.7M
47.3M
2,022
205.2M
-2.15B
2,023
65.1M
-246.5M
2,024
42.9M
-1.44B
2,025
278.3M
-288.6M
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→The company generated $278M of operating cash in 2025. With no profit to compare against, cash generation is the number that matters here.
What this measures
Reported profit against the cash the business actually collected from operating. Profit is an accounting judgement; cash is not.
What good looks like. Cash at or above profit, year after year. Depreciation and other non-cash charges usually push cash above profit, so roughly 100% or more is healthy.
If it rises or falls. Cash falling behind profit for more than a year is the classic early warning: the sales are booked but the money has not arrived, and it shows up in receivables and inventory. For a lender the comparison behaves differently, because a growing loan book consumes cash.
Cash conversion
How much of each sale does CORZ turn into free cash flow?
Period
FCF margin
2020
-0.394
2021
-0.1042
2022
-0.2792
2023
0.0974
2024
-0.102
2025
-1.4129
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
What this measures
Free cash flow as a share of revenue: how much of each dollar of sales survives both costs and capital spending.
What good looks like. A steady or rising share. Asset-light businesses convert far more than manufacturers, so compare a company with itself.
If it rises or falls. Falling conversion while revenue grows means growth is being bought with capital spending or working capital, which is fine while it lasts and painful when it stops.
Spending intensity
How much of its revenue does CORZ spend on capex, R&D and stock pay?
Year
Capex % of rev
R&D % of rev
Stock comp % of rev
2,020
0
0.0874
0.0503
2,021
0
0.0141
0.0715
2,022
0.5997
0.0421
0.2856
2,023
0.0322
0.0143
0.1172
2,024
0.186
0.0232
0.1017
2,025
2.2851
-
0.3079
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→The biggest claim on each sales dollar is capital spending, at 229% of revenue (stock compensation 31%, research and development 2%). That share has risen since 2022, so the cost of competing is climbing.
What this measures
Capital spending, research and development, and stock compensation, each as a share of revenue. The three ways a business pays to keep its position.
What good looks like. A share that is stable or falling while revenue grows, which means the cost of competing is not rising with the business.
If it rises or falls. Rising intensity means each new dollar of sales is getting more expensive to win. Falling intensity can mean efficiency, or it can mean under-investment that shows up years later.
Return on capital employed
Is CORZ's return on capital above what its capital costs?
Period
Return on capital employed
2021
0.0621
2022
-3.3976
2023
0.0401
2024
-0.1059
2025
-0.1568
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→CORZ's return on capital is negative at -15.7% in 2025. The capital in the business is not yet earning anything back.
What this measures
The same return as the card above, but every filed year, against a 10% line that stands in for what capital costs.
What good looks like. Years above the line, and a trend that is flat or rising rather than drifting down towards it.
If it rises or falls. A business earning above its cost of capital creates value by growing; one earning below it destroys value by growing. The 10% line is a convention, not a law, so read the distance from it rather than the crossing.
What does “Quality” actually mean?
Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.
TTM operating cash flow $520M on a net loss of $1.4B
IV
Financial health
●●●●●●1/6
The balance sheet carries real risk. Read the checks before anything else.
-debt unreported
0.9xnear-term bills coverage
-29xearnings ÷ interest bill
$1.8Bcash plus short-term investments
Debt & cash
How much debt does CORZ carry, and do its profits cover the interest?
Year
Total debt
Cash & investments
2,019
-
6.9M
2,020
-
8.7M
2,021
728.2M
117.9M
2,022
36.2M
15.9M
2,023
808.4M
50.4M
2,024
1.09B
836.2M
2,025
1.06B
311.4M
2,026
2.06B
1.77B
◌ each quarterly point is the balance sheet at that quarter end
→Debt of $2.1B sits against $1.8B of cash. Earnings don't currently cover the interest bill at all.
What this measures
Total borrowings against cash on hand, with debt as a multiple of shareholders' equity, and how many times profit covers the interest bill.
What good looks like. Interest covered comfortably - roughly eight times or more - and debt that is not a large multiple of equity.
If it rises or falls. Debt is only a problem when it has to be repaid or refinanced in a bad year, so cover matters more than the amount. Rising debt with rising cover is a business borrowing to grow; rising debt with falling cover is the combination that ends badly.
Near-term liquidity
Do CORZ's current assets cover the bills due within a year?
Period
Current ratio
2021
2.3621
2022
0.4556
2023
0.1986
2024
6.7178
2025
1.1461
◌ 2026 = the latest balance sheet (2026-06-30), not a fiscal year-end · each quarterly point is the balance sheet at that quarter end
→Near-term liquidity is tight: 0.9x of current assets against a dollar due within the year, so CORZ is relying on trading through rather than on what it already holds. That is thinner than in 2021.
What this measures
Current assets over current liabilities: what the company can turn into cash within a year against what it owes within a year.
What good looks like. Comfortably above 1.0, and not falling year after year. Below 1.0 means near-term bills exceed near-term resources, which is normal for some business models and a warning in others.
If it rises or falls. Inventory and receivables build it up; short-term borrowing and payables pull it down. A retailer that turns stock over quickly can run lower than a manufacturer and be perfectly sound.
Cash conversion
How much of CORZ's revenue arrives as operating cash?
Period
Operating cash flow / revenue
2020
-0.394
2021
-0.1042
2022
0.3204
2023
0.1296
2024
0.084
2025
0.8722
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · each quarterly point is the trailing twelve months to that quarter end, so the last one is the current figure
→118.2% of every dollar CORZ sold arrived as operating cash. Up from -39.4% in 2020.
What this measures
Operating cash flow as a share of revenue: of every dollar sold, how much reached the bank before capital spending.
What good looks like. A high share, holding up or improving. It is the clearest sign that reported profit is real.
If it rises or falls. It falls when customers take longer to pay or stock builds up, and it can stay high while profit falls - which is usually the more reassuring of the two.
Shareholders' equity
Is CORZ's shareholder equity (book value) growing?
Equity is below zero after years of buybacks exceeding earnings, so debt-to-equity and return on equity are not published for CORZ: a ratio to a negative base means nothing.
Period
Equity ($)
2019
106.3M
2020
89.2M
2021
1.34B
2022
-409.3M
2023
-596.9M
2024
-943.0M
2025
-962.7M
2026
-2.42B
→Shareholders' equity is negative at -$2.4B: liabilities exceed assets. Usually the mark of heavy buybacks or accumulated losses, and always worth understanding which.
What this measures
What would be left for shareholders if every asset were sold at its book value and every debt repaid. Book value, in other words.
What good looks like. Equity growing as retained profits build up, unless the company is deliberately returning more than it earns.
If it rises or falls. Equity falls for two very different reasons: buybacks, which return money to you, and losses, which do not. The distinction is the whole story, and negative equity means liabilities now exceed assets, which makes debt-to-equity and return on equity meaningless rather than alarming.
What does “Health” actually mean?
Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.
CORZ returns nothing to shareholders yet. Every dollar stays in the business.
+0.00%bought back, TTM, over market value
-at the current rate
$0.00dividends plus buybacks
$94Mlast 12m, dilutes the buybacks
+103.8%since 2020 (split-adjusted)
Capital returned vs stock comp
Do CORZ's buybacks and dividends outweigh the stock it issues to staff?
Year
Buybacks
Dividends
Stock comp
2,022
31.6M
-
182.9M
2,023
-
-
58.9M
2,024
-
-
51.9M
→CORZ returned no cash to shareholders in the latest filed year: everything is being retained or reinvested.
What this measures
Cash returned through buybacks and dividends, alongside the value of new shares issued to employees as compensation.
What good looks like. Returns comfortably larger than stock compensation, so the share count actually falls.
If it rises or falls. A company can announce billions in buybacks while issuing nearly as much stock to staff, and the two largely cancel. What reaches you is the net effect, which is why both bars are here rather than only the buyback.
Share count change (split-adjusted)
Is CORZ's share count rising or falling?
Year
Share-count change
2,021
0.4803
2,022
0.4601
2,023
0.1151
2,024
-0.3265
2,025
0.2433
→The share count grew 24.3% in 2025, averaging 1.1% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
What this measures
The yearly change in the number of shares in issue, adjusted for splits so the years compare. A bar below zero is a falling share count, usually from buybacks; above zero, new shares were issued.
What good looks like. A flat or falling share count. Falling means each share you hold owns a little more of the business every year.
If it rises or falls. A rising count divides the same business among more owners, so your slice shrinks unless profits grow faster. This is the most direct chart on the page: it is your ownership, measured.
Dilution against what it bought
Has CORZ's revenue per share grown faster than its share count?
Change since 2020. The gap between the lines is what each share gained or lost. Share counts are split-adjusted weighted averages.
Year
Share count, change since 2020
Revenue per share, change since 2020
2,020
0
0
2,021
0.4803
5.0976
2,022
1.1614
3.9112
2,023
1.4103
2.4556
2,024
0.6233
4.2154
2,025
1.0182
1.6206
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year · on the quarterly view, revenue per share is the trailing twelve months over that quarter's diluted count
→CORZ issued 102% more shares from 2020 to 2025, but revenue per share still rose 162%. The dilution bought more growth than it cost existing holders.
What this measures
The share count and revenue per share over the same years, both indexed to 100 at the start, so the two lines can be compared directly.
What good looks like. The per-share line above the share-count line: whatever the company did with its shares, more business ended up behind each one.
If it rises or falls. Issuing shares is not automatically bad. It is bad when the money raised buys less growth than the dilution cost, which is exactly what the gap between these two lines shows.
Why compare buybacks with stock compensation?
A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.
→CORZ is in a downtrend: the price is below the cloud where recent trading settled and that cloud is still falling. Both shorter readings point down as well, so nothing here disagrees with the downtrend.
How the trend above is worked out
The trend read is the daily Ichimoku picture, the same indicator drawn on the chart above. Five names, and what each one is: the TENKAN is the midpoint of the last 9 sessions' high and low, the fast line; the KIJUN is the same over 26 sessions, the slow one; the two SENKOU spans are midpoints drawn 26 sessions into the FUTURE, and the band between them is the KUMO cloud - because it is drawn forward, the support for the coming weeks is already fixed and a change of its direction can be seen coming; the CHIKOU is today's close compared with the close 26 sessions back. A trend confirms itself in that order and the checks follow it: price clears the cloud, holds above both lines, the Tenkan crosses above the Kijun, the cloud ahead turns up, and the Chikou stands higher than the price a month ago. Six of six therefore means all of that at once; a price sitting inside the cloud, or below its own lines, cannot get there. The last check is the one Ichimoku cannot answer - whether the S&P 500 did better over 12 months (252 sessions), measured on the SPY ETF with dividends included, on the same adjusted basis as the stock's own price. Our figures are the last close we hold, refreshed every trading night; the chart is live. None of this says anything about the business, and it is not advice.
Are CORZ's insiders buying or selling shares with their own money?
Month
Buys ($)
Sells ($)
2024-01
0
0
2024-02
0
0
2024-03
1.2M
0
2024-04
0
0
2024-05
0
15,595
2024-06
0
365,950
2024-07
0
0
2024-08
550,256
191,384
2024-09
233,782
0
2024-10
0
0
2024-11
0
2.3M
2024-12
0
0
2025-01
0
9.6M
2025-02
0
0
2025-03
551,257
1.4M
2025-04
0
229,794
2025-05
1.2M
561,585
2025-06
0
1.4M
2025-07
0
0
2025-08
0
0
2025-09
0
0
2025-10
0
0
2025-11
107,500
0
2025-12
0
0
2026-01
0
0
2026-02
0
0
2026-03
101,700
0
2026-04
0
910,977
2026-05
0
935,024
2026-06
0
1.4M
2026-07
0
883,200
2026-08
244,352
959,882
2026-09
97,980
709,429
2026-10
0
314,216
→Since January 2024, insiders bought $4M and sold $22M on the open market, a net sale of $18M. A further 132 transactions were grants, option exercises or tax withholding, which say nothing either way.
What this measures
Open-market buys and sells by the company's own officers and directors, from their Form 4 filings. Grants, option exercises and shares withheld for tax are excluded, because they are compensation rather than decisions.
What good looks like. Buying with their own money, which is the one insider action that is hard to explain away.
If it rises or falls. Selling is weak evidence: insiders sell to diversify, to buy houses, and on pre-scheduled plans set months ahead. Buying is stronger evidence, because there is only one reason to do it. The absence of any buying over a long stretch is itself worth noticing.
The record
Who did what, exactly?
Date
Insider
Role
Type
Shares
Price
Value
2026-10-12
Todd M Duchene
See remarks
SELL
10,000
$15.12
$151,160
2026-10-05
Todd M Duchene
See remarks
SELL
10,000
$16.31
$163,056
2026-10-01
Adam Taylor Sullivan
Chief Executive Officer
tax
23,508
$15.98
$375,658
2026-10-01
Todd M Duchene
See remarks
tax
8,228
$15.98
$131,483
2026-09-28
Todd M Duchene
See remarks
SELL
10,000
$16.76
$167,586
2026-09-21
Todd M Duchene
See remarks
SELL
10,000
$18.37
$183,746
2026-09-15
Eric Stanton Weiss
Director
BUY
6,000
$16.33
$97,980
2026-09-14
Todd M Duchene
See remarks
SELL
10,000
$17.14
$171,362
2026-09-08
Todd M Duchene
See remarks
SELL
10,000
$18.67
$186,735
2026-08-31
Todd M Duchene
See remarks
SELL
10,000
$16.23
$162,340
2026-08-24
Todd M Duchene
See remarks
SELL
10,000
$17.45
$174,493
2026-08-20
Elizabeth Crain
Director
BUY
6,000
$18.33
$109,994
2026-08-18
Eric Stanton Weiss
Director
BUY
7,000
$19.19
$134,358
2026-08-17
Todd M Duchene
See remarks
SELL
10,000
$20.10
$200,974
2026-08-17
Todd M Duchene
See remarks
tax
11,205
$20.13
$225,557
2026-08-10
Todd M Duchene
See remarks
SELL
9,000
$19.90
$179,087
2026-08-10
Todd M Duchene
See remarks
SELL
1,000
$20.65
$20,648
2026-08-03
Todd M Duchene
See remarks
SELL
1,000
$20.39
$20,390
2026-08-03
Todd M Duchene
See remarks
SELL
1,500
$21.55
$32,325
2026-08-03
Todd M Duchene
See remarks
SELL
7,500
$22.62
$169,625
2026-07-27
Todd M Duchene
See remarks
SELL
8,300
$20.75
$172,199
2026-07-27
Todd M Duchene
See remarks
SELL
1,600
$21.89
$35,028
2026-07-27
Todd M Duchene
See remarks
SELL
100
$22.49
$2,249
2026-07-20
Todd M Duchene
See remarks
SELL
10,000
$22.30
$222,995
2026-07-16
Adam Taylor Sullivan
Chief Executive Officer
tax
15,584
$22.72
$354,068
2026-07-16
Todd M Duchene
See remarks
tax
4,325
$22.72
$98,264
2026-07-13
Todd M Duchene
See remarks
SELL
9,700
$22.43
$217,572
2026-07-13
Todd M Duchene
See remarks
SELL
300
$23.01
$6,903
2026-07-06
Todd M Duchene
See remarks
SELL
10,000
$22.63
$226,254
2026-06-30
Adam Taylor Sullivan
Chief Executive Officer
tax
18,023
$25.59
$461,209
2026-06-30
Todd M Duchene
See remarks
tax
5,469
$25.59
$139,952
2026-06-29
Todd M Duchene
See remarks
SELL
8,800
$25.99
$228,701
2026-06-29
Todd M Duchene
See remarks
SELL
1,100
$27.42
$30,162
2026-06-29
Todd M Duchene
See remarks
SELL
100
$27.95
$2,795
2026-06-22
Todd M Duchene
See remarks
SELL
7,600
$29.11
$221,238
2026-06-22
Todd M Duchene
See remarks
SELL
2,400
$29.88
$71,701
2026-06-15
Todd M Duchene
See remarks
SELL
9,900
$28.19
$279,056
2026-06-15
Todd M Duchene
See remarks
SELL
100
$28.79
$2,879
2026-06-08
Todd M Duchene
See remarks
SELL
5,500
$26.64
$146,507
2026-06-08
Todd M Duchene
See remarks
SELL
4,500
$27.11
$121,974
2026-06-01
Todd M Duchene
See remarks
SELL
1,300
$26.93
$35,007
2026-06-01
Todd M Duchene
See remarks
SELL
3,200
$28.27
$90,453
2026-06-01
Todd M Duchene
See remarks
SELL
5,500
$28.76
$158,159
2026-05-26
Todd M Duchene
See remarks
SELL
10,000
$26.25
$262,540
2026-05-18
Todd M Duchene
See remarks
SELL
9,600
$23.12
$221,994
2026-05-18
Todd M Duchene
See remarks
SELL
400
$23.76
$9,503
2026-05-11
Todd M Duchene
See remarks
SELL
2,600
$22.82
$59,322
2026-05-11
Todd M Duchene
See remarks
SELL
7,400
$23.39
$173,098
2026-05-04
Todd M Duchene
See remarks
SELL
9,900
$20.85
$206,414
2026-05-04
Todd M Duchene
See remarks
SELL
100
$21.53
$2,153
2026-04-27
Todd M Duchene
See remarks
SELL
10,000
$20.94
$209,390
2026-04-20
Todd M Duchene
See remarks
SELL
10,000
$19.80
$197,952
2026-04-16
Todd M Duchene
See remarks
tax
16,741
$19.08
$319,418
2026-04-15
Adam Taylor Sullivan
Chief Executive Officer
tax
87,355
$19.08
$1.67M
2026-04-13
Todd M Duchene
See remarks
SELL
9,600
$18.61
$178,650
2026-04-13
Todd M Duchene
See remarks
SELL
400
$18.99
$7,597
Why do the transaction types matter so much?
Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.
VIII
Ownership
informational
128.4%on Form 13F, 30 June 2026
6.1%officers, directors, founders
56.5%together
3of the 18 TenQ follows
Top holders
Who owns Core Scientific stock?
Fund managers filing Form 13F held 128.4% of the company's shares on 30 June 2026. The largest holder is BlackRock, Inc., with 8.8%. Insiders hold 6.1%.
#
Holder
Stake
Shares
Value
Change
1
BlackRock, Inc.Fund manager
8.75%
28.1M
$379M
+14.5%
2
Situational Awareness LPFund manager
8.09%
26.0M
$351M
+0.3%
3
Jericho Capital Asset Management L.P.Fund manager
7.12%
22.9M
$308M
+95.7%
4
Kenneth GriffinHolds over 5% · Form 13G, 29 July 2026
6.49%
20.9M
$281M
-
5
Vanguard Portfolio Management LLCFund manager
5.81%
18.7M
$252M
+0.5%
6
UBS Group AGFund manager
4.98%
16.0M
$216M
-37.4%
7
G1 Execution Services, LLCHolds over 5% · Form 13G, 31 March 2025
4.55%
14.6M
$197M
-
8
Vanguard Capital Management LLCFund manager
4.29%
13.8M
$186M
+3.5%
9
Two Sigma Investments, LPFund manager
3.20%
10.3M
$139M
+84.5%
10
Ascentis Wealth Management, LLCFund manager
3.19%
10.3M
$138M
+6.6%
11
Two Seas Capital LPFund manager
2.88%
9.2M
$125M
-43.3%
12
Value Aligned Research Advisors, LLCFund manager
2.86%
9.2M
$124M
+19.4%
13
Geode Capital Management, LLCFund manager
2.64%
8.5M
$115M
+9.2%
14
State Street CorpFund manager
2.41%
7.7M
$104M
+6.6%
15
Valiant Capital Management, L.P.Fund manager
2.33%
7.5M
$101M
+9.4%
16
Point72 Asset Management, L.P.Fund manager
2.11%
6.8M
$92M
+20.7%
17
Jane Street Group, LLCFund manager
2.01%
6.5M
$87M
+10492.8%
18
Morgan StanleyFund manager
1.97%
6.3M
$85M
+83.1%
19
Polar Asset Management Partners Inc.Fund manager
1.76%
5.6M
$76M
+141.3%
20
LMR Partners LLPFund manager
1.71%
5.5M
$74M
+7.9%
The full list of top holders is free with an account
Source: SEC Form 13F filings for the quarter to 30 June 2026, Schedules 13D and 13G, and Form 4. Shares on today's basis, value at the latest price.
Super investors
Which super investors own Core Scientific stock?
George Soros's Soros Fund Management holds Core Scientific, 0.7% of its portfolio, as of 30 June 2026. 3 of the 18 super investors TenQ follows hold it.
Source: each firm's Form 13F for the quarter to 30 June 2026, and its Form 4 and Schedules 13D and 13G since. A weight is the holding's share of the firm's 13F portfolio. All super investors
Where does this list come from?
Fund managers with more than $100 million in US stocks report their holdings every quarter on Form 13F, up to 45 days after the quarter ends, so the fund figures are as of the last quarter end. A fund family reports as one manager, and funds together can report more than 100%: shares lent to short sellers are bought again by other funds, and both report them. Anyone holding more than 5% of a class files a Schedule 13D or 13G, and officers and directors report what they hold on Form 4 after every trade, so those rows carry their own dates. Short positions are not reported anywhere. A stake is the holder's shares as a share of all the company's shares, with other share classes converted at their market value.